United States v. Hakop Gambaryan ( 2018 )


Menu:
  •                            NOT FOR PUBLICATION                           FILED
    UNITED STATES COURT OF APPEALS                       MAR 29 2018
    MOLLY C. DWYER, CLERK
    U.S. COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    UNITED STATES OF AMERICA,                       No.    16-50409
    Plaintiff–Appellee,             D.C. No.
    2:14-cr-00249-ODW
    v.
    HAKOP GAMBARYAN,                                MEMORANDUM*
    Defendant–Appellant.
    Appeal from the United States District Court
    for the Central District of California
    Otis D. Wright II, District Judge, Presiding
    Submitted March 28, 2018**
    Pasadena, California
    Before: REINHARDT and WARDLAW, Circuit Judges, and KORMAN,***
    District Judge.
    Hakop Gambaryan was convicted of health care fraud in violation of 18
    U.S.C. § 1347, and was sentenced to eighty-four months in prison. On appeal, we
    *
    This disposition is not appropriate for publication and is not precedent
    except as provided by Ninth Circuit Rule 36-3.
    **
    The panel unanimously concludes this case is suitable for decision
    without oral argument. See Fed. R. App. P. 34(a)(2).
    ***
    The Honorable Edward R. Korman, United States District Judge for
    the Eastern District of New York, sitting by designation.
    held that the eighteen-level loss enhancement based on the amount of the fraud was
    unsupported by clear and convincing evidence, and that an enhancement for
    defrauding a federal health care program violated the ex post facto clause. United
    States v. Gambaryan, 654 Fed. App’x. 888 (9th Cir. 2016). We observed, however,
    that the absence of the federal health care program enhancement might be canceled
    out by the addition of the abuse-of-trust enhancement, which applied to medical
    supply providers. 
    Id. at 891
    (citing United States v. Adebimpe, 
    819 F.3d 1212
    , 1214
    (9th Cir. 2016)).
    On remand, the district judge applied the abuse-of-trust enhancement, holding
    that Adebimpe was “directly on point,” and justified a two-level enhancement for
    abuse of trust. The judge then calculated the sentencing range to be fifty-one to sixty-
    three months, and resentenced Gambaryan to sixty-three months in prison. On this
    appeal, Gambaryan argues that the district court erred in relying on Adebimpe to
    increase his offense level for abuse of a position of trust. We disagree.
    1. While Gambaryan is correct that Adebimpe “did not hold that all medical
    suppliers hold a position of public or private trust,” the district court did not clearly
    err in finding that Gambaryan did. See United States v. Jennings, 
    711 F.3d 1144
    ,
    1146 (9th Cir. 2013) (factual findings supporting a sentencing enhancement are
    reviewed for clear error). In Adebimpe, testimony revealed that “[b]oth the physician
    and the equipment supplier have responsibility to ensure the patient receives the
    appropriate equipment,” and that there exists “an independent responsibility for each
    side to get it right.” 
    Adebimpe, 819 F.3d at 1216
    . Evidence also showed that the
    medical documentation for the wheelchairs was “woefully inadequate,” and that
    recipients testified “nobody had assessed their homes to determine whether their
    homes could accommodate the wheelchairs.” 
    Id. Under these
    circumstances, the
    evidence established that suppliers “have professional obligations separate from
    those of a physician.” 
    Id. at 1219.
    Similar evidence was presented here. Fraud investigator Monica Nolan
    testified that durable medical equipment suppliers such as Gambaryan have a duty
    to confirm the medical necessity of prescription equipment even though they are not
    physicians writing prescriptions. Kurt Soo Hoo, an investigator with the Department
    of Health and Human Services, testified that none of the power wheelchairs had been
    prescribed by a primary care physician with adequate knowledge of the patient, and
    that patient files contained hundreds of photocopied beneficiary signatures,
    including some of beneficiaries who had died before the date on their patient file.
    Finally, wheelchair recipients testified that Gambaryan never took measurements or
    conducted inspections of their homes upon delivery of the wheelchairs to ensure that
    the equipment could be properly used. On this record, the district court did not
    clearly err in finding that Gambaryan occupied a position of trust because of his
    independent obligation to ensure that the wheelchairs were appropriate, and bore that
    responsibility when submitting claims to Medicare that he verified were truthful and
    accurate. See 
    Adebimpe, 819 F.3d at 1220
    .
    2. The district court did not plainly err in ordering Gambaryan to pay $696,851
    in restitution to Medicare. Gambaryan presented no evidence to support his
    statement at sentencing that he had already reimbursed Medicare $100,000, and the
    Pre-Sentence Report indicated the opposite—that Gambaryan lacked sufficient
    funds to make restitution payments.1
    AFFIRMED.
    1
    The motion to withdraw as counsel by the Office of the Federal Public Defender
    for the Central District of California is granted. Attorney Michael Tanaka is
    substituted in as counsel, effective March 2, 2018.
    

Document Info

Docket Number: 16-50409

Filed Date: 3/29/2018

Precedential Status: Non-Precedential

Modified Date: 4/18/2021